Myeloma Trial, Recruiting NCT02134574 Sponsor: University Hospital, Montpellier Condition: Myeloma
Back to Myeloma

Myeloma Trial, Recruiting

NCT02134574
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who are being seen as an outpatient or are staying in hospital with a suspected blood cancer that needs further investigation, OR people who have already been diagnosed with a blood cancer within the last 6 months at the time of signing the consent form
  • People who have signed a consent form agreeing to take part in the trial
  • People who are covered by a social security (health insurance) scheme

Who may not be able to join:

  • People who are under 18, or adults who are legally protected (meaning someone else has legal responsibility for their decisions) (confirm with trial site)
  • People who have already received treatment for a blood cancer or blood disorder

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 February 2014
Est. completion
1 June 2033

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Survival with 2 years

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov